Diagnostic Testing for Encephalitis, Part I

Clinical Microbiology Newsletter

Volumn 32, Issue 3, 2010, Pages 17-23

  Reznicek, Julie E ^a   Bloch, Karen C ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CHICKENPOX VACCINE; DOXYCYCLINE; GADOLINIUM; IMMUNOGLOBULIN M;

ANAMNESIS; ANTIBODY DETECTION; ARTICLE; BRAIN BIOPSY; CEREBROSPINAL FLUID ANALYSIS; CHICKENPOX; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; CONTRAST ENHANCEMENT; CYTOMEGALOVIRUS; DIAGNOSTIC TEST; EHRLICHIA; ENCEPHALITIS; ENTEROVIRUS; ENVIRONMENTAL EXPOSURE; EPSTEIN BARR VIRUS; FEVER; GRAM STAINING; HEADACHE; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS; HERPES VIRUS; HUMAN; HUMAN GRANULOCYTIC ANAPLASMOSIS; HUMAN HERPESVIRUS 6; IMMUNOFLUORESCENCE TEST; MEDICAL ASSESSMENT; MICROBIOLOGICAL EXAMINATION; MICROSCOPY; NEUROLOGIC DISEASE; NORTH AMERICA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEIC ACID AMPLIFICATION; PARASITE VECTOR; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROPHYLAXIS; PUBLIC HEALTH SERVICE; RICKETTSIA RICKETTSII; ROCKY MOUNTAIN SPOTTED FEVER; SEROLOGY; SYMPTOM; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VARICELLA ZOSTER VIRUS; VIRUS CULTURE; VIRUS ENCEPHALITIS;

EID: 74049164166     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2010.01.001     Document Type: Article

References (67)

1. Roos K.L. Encephalitis. Neurol. Clin. 17 (1999) 813-833
2. Solomon T., Hart I.J., and Beeching N.J. Viral encephalitis: a clinician's guide. Pract. Neurol. 7 (2007) 288-305
3. Whitley R.J., and Gnann J.W. Viral encephalitis: familiar infections and emerging pathogens. Lancet 359 (2002) 507-513
4. Romero J.R., and Newland J.G. Viral meningitis and encephalitis: traditional and emerging viral agents. Semin. Pediatr. Infect. Dis. 14 (2003) 72-82
5. Glaser C.A., et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin. Infect. Dis. 43 (2006) 1565-1577
6. Garg R.K. Acute disseminated encephalomyelitis. Postgrad. Med. J. 79 (2003) 11-17
7. Young N.P., Weinshenker B.G., and Lucchinetti C.F. Acute disseminated encephalomyelitis: current understanding and controversies. Semin. Neurol. 28 (2008) 84-94
8. Beghi E., et al. Encephalitis and aseptic meningitis, Olmsted County, Minnesota, 1950-1981: I. Epidemiology. Ann. Neurol. 16 (1984) 283-294
9. Khetsuriani N., Holman R.C., and Anderson L.J. Burden of encephalitis-associated hospitalizations in the United States, 1988-1997. Clin. Infect. Dis. 35 (2002) 175-182
10. Koskiniemi M., and Vaheri A. Effect of measles, mumps, rubella vaccination on pattern of encephalitis in children. Lancet i (1989) 31-34
11. Tunkel A.R., et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 47 (2008) 303-327
12. Polage C.R., and Petti C.A. Assessment of the utility of viral culture of cerebrospinal fluid. Clin. Infect. Dis. 43 (2006) 1578-1579
13. Barnett N.D., et al. Primary amoebic meningoencephalitis with Naegleria fowleri: clinical review. Pediatr. Neurol. 15 (1996) 230-234
14. Reiber H., and Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin. Chem. 37 (1991) 1153-1160
15. Monteyne P., et al. The detection of intrathecal synthesis of anti-herpes simplex IgG antibodies: comparison between an antigen-mediated immunoblotting technique and antibody index calculations. European Union Concerted Action on Virus Meningitis and Encephalitis. J. Med. Virol. 53 (1997) 324-331
16. Steiner I., et al. Viral encephalitis: a review of diagnostic methods and guidelines for management. Eur. J. Neurol. 12 (2005) 331-343
17. Doong H., et al. Duplex eQ-PCR for simultaneous detection and differentiation of herpes simplex viruses and enteroviruses in cerebrospinal fluid. Proc. 108th Gen. Meet. Am. Soc. Microbiol. (2008)
18. Espy M.J., et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin. Microbiol. Rev. 19 (2006) 165-256
19. Lakeman F.D., and Whitley R.J. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J. Infect. Dis. 171 (1995) 857-863
20. Allawi H.T., et al. Invader plus method detects herpes simplex virus in cerebrospinal fluid and simultaneously differentiates types 1 and 2. J. Clin. Microbiol. 44 (2006) 3443-3447
21. Tang Y.W., et al. Comparative evaluation of colorimetric microtiter plate systems for detection of herpes simplex virus in cerebrospinal fluid. J. Clin. Microbiol. 36 (1998) 2714-2717
22. Weinberg A., et al. Dual infections of the central nervous system with Epstein-Barr virus. J. Infect. Dis. 191 (2005) 234-237
23. Schloss L., et al. An international external quality assessment of nucleic acid amplification of herpes simplex virus. J. Clin. Virol. 28 (2003) 175-185
24. O'Sullivan, C.E., et al. Clinical spectrum and laboratory characteristics associated with detection of herpes simplex virus DNA in cerebrospinal fluid. Mayo Clin. Proc. 78 (2003) 1347-1352
25. Steiner I., Kennedy P.G., and Pachner A.R. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol. 6 (2007) 1015-1028
26. Whitley R.J., and Lakeman F. Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Clin. Infect. Dis. 20 (1995) 414-420
27. Whitley R.J. Herpes simplex encephalitis: adolescents and adults. Antivir. Res. 71 (2006) 141-148
28. Whitley R.J., et al. Herpes simplex encephalitis. Clinical assessment. JAMA 247 (1982) 317-320
29. Domingues R.B., et al. Diagnosis of herpes simplex encephalitis by magnetic resonance imaging and polymerase chain reaction assay of cerebrospinal fluid. J. Neurol. Sci. 157 (1998) 148-153
30. Tang Y.W. Laboratory diagnosis of CNS infections by molecular amplification techniques. Exp. Opin. Med. Diagn. 1 (2007) 489-509
31. Tyler K.L. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's. Herpes 11 Suppl. 2 (2004) 57A-64A
32. Cinque P., et al. The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis. J. Neurol. Neurosurg. Psychiatry 61 (1996) 339-345
33. Malm G., and Forsgren M. Neonatal herpes simplex virus infections: HSV DNA in cerebrospinal fluid and serum. Arch. Dis. Child Fetal Neonatal Ed. 81 (1999) F24-F29
34. Gilden D.H., et al. Herpesvirus infections of the nervous system. Nat. Clin. Pract. Neurol. 3 (2007) 82-94
35. Zerr D.M. Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation. J. Clin. Virol. 37 Suppl. 1 (2006) S52-S56
36. Arribas J.R., et al. Cytomegalovirus encephalitis. Ann. Intern. Med. 125 (1996) 577-587
37. Crawford D.H., et al. A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis. Clin. Infect. Dis. 43 (2006) 276-282
38. Weinberg A., et al. Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system. Ann. Neurol. 52 (2002) 543-548
39. Portegies P., and Corssmit N. Epstein-Barr virus and the nervous system. Curr. Opin. Neurol. 13 (2000) 301-304
40. Straus S.E., et al. NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management. Ann. Intern. Med. 118 (1993) 45-58
41. Corcoran C., et al. The predictive value of cerebrospinal fluid Epstein-Barr viral load as a marker of primary central nervous system lymphoma in HIV-infected persons. J. Clin. Virol. 42 (2008) 433-436
42. Gilden D.H., et al. Neurologic complications of the reactivation of varicella-zoster virus. N. Engl. J. Med. 342 (2000) 635-645
43. Gnann Jr. J.W. Varicella-zoster virus: atypical presentations and unusual complications. J Infect. Dis. 186 Suppl. 1 (2002) S91-S98
44. Kleinschmidt-DeMasters, B.K., and Gilden D.H. Varicella-zoster virus infections of the nervous system: clinical and pathologic correlates. Arch. Pathol. Lab. Med. 125 (2001) 770-780
45. Koskiniemi M., et al. Acute central nervous system complications in varicella zoster virus infections. J. Clin. Virol. 25 (2002) 293-301
46. Gregoire S.M., et al. Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system. J. Neurol. Neurosurg. Psychiatry 77 (2006) 938-942
47. Burke D.G., et al. Polymerase chain reaction detection and clinical significance of varicella-zoster virus in cerebrospinal fluid from human immunodeficiency virus-infected patients. J. Infect. Dis. 176 (1997) 1080-1084
48. Modlin J.F., et al. Focal encephalitis with enterovirus infections. Pediatrics 88 (1991) 841-845
49. Rotbart H.A. Enteroviral infections of the central nervous system. Clin. Infect. Dis. 20 (1995) 971-981
50. Huang C.C., et al. Neurologic complications in children with enterovirus 71 infection. N. Engl. J. Med. 341 (1999) 936-942
51. Rotbart H.A., et al. Diagnosis of enteroviral meningitis by using PCR with a colorimetric microwell detection assay. J. Clin. Microbiol. 32 (1994) 2590-2592
52. Kupila L., et al. Diagnosis of enteroviral meningitis by use of polymerase chain reaction of cerebrospinal fluid, stool, and serum specimens. Clin. Infect. Dis. 40 (2005) 982-987
53. Chung P.W., et al. Duration of enterovirus shedding in stool. J. Microbiol. Immunol. Infect. 34 (2001) 167-170
54. Harrell G.T. Rickettsial involvement of the nervous system. Med. Clin. North Am. 37 (1953) 395-422
55. Treadwell T.A., et al. Rocky Mountain spotted fever in the United States, 1993-1996. Am. J. Trop. Med. Hyg. 63 (2000) 21-26
56. Kirk J.L., et al. Rocky Mountain spotted fever. A clinical review based on 48 confirmed cases, 1943-1986. Medicine (Baltimore) 69 (1990) 35-45
57. Thorner A.R., Walker D.H., and Petri Jr. W.A. Rocky mountain spotted fever. Clin. Infect. Dis. 27 (1998) 1353-1359
58. Sexton D.J., and Corey G.R. Rocky Mountain "spotless" and "almost spotless" fever: a wolf in sheep's clothing. Clin. Infect. Dis. 15 (1992) 439-448
59. Chapman A.S., et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis-United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm. Rep. 55 (2006) 1-27
60. Dalton M.J., et al. National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am. J. Trop. Med. Hyg. 52 (1995) 405-413
61. Thomas L.D., et al. Human ehrlichiosis in transplant recipients. Am. J. Transplant. 7 (2007) 1641-1647
62. Demma L.J., et al. Epidemiology of human ehrlichiosis and anaplasmosis in the United States, 2001-2002. Am. J. Trop. Med. Hyg. 73 (2005) 400-409
63. Ratnasamy N., et al. Central nervous system manifestations of human ehrlichiosis. Clin. Infect. Dis. 23 (1996) 314-319
64. Harkess J.R., Stucky D., and Ewing S.A. Neurologic abnormalities in a patient with human ehrlichiosis. South Med. J. 83 (1990) 1341-1343
65. Schutze G.E., et al. Human monocytic ehrlichiosis in children. Pediatr. Infect. Dis. J. 26 (2007) 475-479
66. Standaert S.M., et al. Primary isolation of Ehrlichia chaffeensis from patients with febrile illnesses: clinical and molecular characteristics. J. Infect. Dis. 181 (2000) 1082-1088
67. Olano J.P., et al. Human monocytotropic ehrlichiosis, Missouri. Emerg. Infect. Dis. 9 (2003) 1579-1586